Latest Report

NIVF

NIVF Doubles Premarket Off Its $0.07 Offering Price — Anatomy of a Dilution-Cycle Bounce

September 30, 2026 — 8:38 AM EDT

NIVF is up triple digits premarket with no new headline — a structural bounce off the $0.07 offering price that just nine-folded the share count. Here's how the machine works and the levels that matter.

$0.16 +116.67% Vol: 304.42M Float: 931.9K
Read Report →

Get reports like this in your inbox. Free.

Small-cap equity research on the day's most active names, before the bell.

No spam. No upsells. Unsubscribe anytime.

Recent Research

Recent Reports

NIVF

NIVF Doubles Premarket Off Its $0.07 Offering Price — Anatomy of a Dilution-Cycle Bounce

Sep 30, 2026

NIVF is up triple digits premarket with no new headline — a structural bounce off the $0.07 offering price that just nine-folded the share count. Here's how the machine works and the levels that matter.

Read →
FRGT

FRGT Rips Pre-Market on Zero News — A Sub-600K Float Doing What Sub-600K Floats Do

Sep 30, 2026

Freight Technologies is up 35%+ pre-market with no news anywhere — just a float under 600K shares getting turned over dozens of times before the open. Here's the bracket that matters.

Read →
BKYI

BKYI Rips 40%+ Premarket on Gulf Partnership — But the Warrant Vote Friday Is the Real Story

Sep 29, 2026

BIO-key gapped over 40% premarket on a Gulf-region partnership announcement — but with a sub-1.5M float, a faded spike, and a 1.24M-share warrant vote set for Friday, the supply math deserves as much attention as the headline.

Read →
SLXN

SLXN Nearly Doubles Overnight on SIL204 Data — But the Regular Session Ignored the Same News for Six Hours

Sep 29, 2026

SLXN nearly doubled overnight on SIL204 preclinical data the regular session ignored for six hours — a momentum-discovery move on a share structure that's grown 6x in a quarter, with an ATM live and a fourth reverse split pending.

Read →
WBUY

WBUY: Grocery App Turned Travel Company Doubles Revenue, and the Float Can't Handle It

Sep 28, 2026

Webuy Global gapped hard premarket Monday after reporting H1 2026 revenue up 94% to $14.3M as its grocery-to-travel pivot completed — and a sub-3M float turned the news into a violent auction before the bell.

Read →
MEDS

MEDS Gaps 30% Pre-Market on GLP-1 App Launch — But the Convertible Note Machinery Sets the Ceiling

Sep 28, 2026

DataMeds AI delivered its promised GLP-1 app launch with NFL Alumni Health and the stock gapped ~30% pre-market on massive float rotation — but convertible notes that price off the prior close, plus 34M registered resale shares, define the ceiling.

Read →
View All Reports →

Reference Desk

More than reports — a reference desk for small-cap runners

Every report links back into a growing public record you can check for yourself.

The Runners Log

Every mover we've documented and how it resolved.

145 Movers documented · 50% traded higher day 2

Explore the log → Pattern Guides

The four recurring small-cap setups — mechanics, tells, how they end.

See the patterns → Ticker Run Histories

Repeat runners, float fingerprints, dilution filings across our coverage.

See a run history → Branded PDF Reports

Every report downloadable as a research-desk PDF.

Browse reports →

Built To Be Checked

Built to be checked.

Machine-verified numbers

Price, float, volume, and filings in every report are machine-sourced and cross-checked. The writer never types a number.

A ledger with no edit button

Every published report stays on the Runners Log — winners, losers, halts. Look it up before you trust us. See the log →

About Us

What is Free Equity Reports?

Free Equity Reports is a Small Cap Research publication that publishes daily analysis of small-cap companies and the day's most active names.

Each report covers catalysts, SEC filing analysis, dilution risk, float and share structure, and an honest assessment of whether the setup still makes sense for traders.

Reports are written for active retail traders who want real research — not hype, not spam, not recycled press releases. Every report is published free, every trading day, before the market opens.

Tomorrow's research, before the open.

Join readers who get our small-cap research before the market opens.

No spam. No upsells. Unsubscribe anytime.